Tyr667

Site Information
AAPMFVKySTITRLQ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 34668887
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 )
Disease tissue studied:	gastric cancer ( 7 ) , gastric carcinoma ( 7 ) , lung cancer ( 1 , 2 , 3 , 4 ) , non-small cell lung cancer ( 1 , 2 , 3 , 4 ) , non-small cell lung adenocarcinoma ( 1 , 2 , 3 , 4 ) , non-small cell large cell lung carcinoma ( 2 , 3 )
Relevant cell line - cell type - tissue:	A549 (pulmonary) ( 1 ) , Cal-12T (pulmonary) ( 4 ) , HCC44 (pulmonary) ( 4 ) , HCC78 (pulmonary) ( 3 ) , lung ( 1 , 2 , 3 , 4 ) , MKN-45 (gastric) ( 7 ) , NCI-H1299 (pulmonary) ( 2 ) , NCI-H1355 (pulmonary) ( 1 ) , NCI-H1437 (pulmonary) ( 4 ) , NCI-H1666 (pulmonary) ( 4 ) , NCI-H1734 (pulmonary) ( 2 ) , NCI-H1781 (pulmonary) ( 3 ) , NCI-H1792 (pulmonary) ( 1 ) , NCI-H1944 (pulmonary) ( 2 ) , NCI-H2228 (pulmonary) ( 3 ) , NCI-H23 (pulmonary) ( 1 ) , NCI-H2405 (pulmonary) ( 4 ) , NCI-H3122 (pulmonary) ( 3 ) , NCI-H358 (pulmonary) ( 2 ) , NCI-H441 (pulmonary) ( 1 ) , NCI-H460 (pulmonary) ( 2 ) , NCI-H661 (pulmonary) ( 3 )

References
1	Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
2	Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
3	Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
4	Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
5	Rikova K (2012) CST Curation Set: 14270; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 1mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]) Curated Info
6	Rikova K (2012) CST Curation Set: 14271; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 2mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]) Curated Info
7	Zhou J (2012) CST Curation Set: 13884; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876 Curated Info